Brief: Nicox's Licensee Bausch+Lomb Receives Approval For VYZULTA In UAE

Nicox SA

25/06/2021 06:33

June 25 (Reuters) - Nicox SA  NCOX.PA :
    * REG-NICOX’S LICENSEE BAUSCH + LOMB RECEIVES APPROVAL FOR
VYZULTA® (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024% IN
THE UNITED ARAB EMIRATES
    * UNDER AGREEMENT, NICOX RECEIVES INCREASING TIERED
ROYALTIES OF
6% TO 12% ON NET GLOBAL SALES OF VYZULTA
    * UNDER AGREEMENT RECEIVES ALSO UP TO $150 MILLION IN
POTENTIAL
FUTURE MILESTONE PAYMENTS

Source text for Eikon:  ID:nGNElTjfj 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))